Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Fundacion Del Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion

Clinical trials sponsored by Fundacion Del Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion, explained in plain language.

Not yet recruiting 1

New inhaled treatment aims to save lungs and reduce ventilator time in ICU patients

Disease control Not yet recruiting

This study tests whether an inhaled drug called aprotinin can improve outcomes for adults with moderate to severe acute respiratory distress syndrome (ARDS), a life-threatening lung condition. About 156 critically ill patients in intensive care will receive either aprotinin or a …

Phase: PHASE3 • Sponsor: Fundacion del Hospital Nacional de Paraplejicos para la Investigacion y la Integracion • Aim: Disease control

Last updated Jun 27, 2026 08:10 UTC